Clinical trial NCT02296138: Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.
Official title: A Randomised, Double-blind, Active-controlled Parallel Group Study to Evaluate the Effect of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared With Tiotropium on Chronic Obstructive Pulmonary Disease (COPD) Exacerbation in Patients With Severe to Very Severe COPD. [DYNAGITO]
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Pulmonary Disease, Chronic Obstructive
Lead sponsor: Boehringer Ingelheim
Sponsor class: INDUSTRY
First posted: 2014-11-20
Enrollment: 7903
Sex: ALL
Minimum age (years): 40
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The overall objective is to assess the effect of once daily tiotropium + olodaterol fixed dose combination compared to 5 µg tiotropium (both delivered with the Respimat® inhaler) on moderate to severe COPD exacerbation in patients with severe to very severe COPD.


Eligibility criteria: Inclusion criteria:

* Male or female patients, 40 years of age or older.
* Diagnosis of COPD with a documented post-bronchodilator Forced expiratory volume in one second (FEV1)\< 60% of predicted normal and a post-bronchodilator FEV1/ forced vital capacity (FVC) \<70% at Visit 1
* Documented history of at least one moderate to severe COPD exacerbation in the previous 12 months requiring treatment with systemic corticosteroids and/or antibiotics and/or related hospitalization.
* Symptomatically stable as defined by: no evidence of COPD exacerbation requiring use of either antibiotics and/or steroids 4 weeks prior to visit 1 and no evidence of change in their usual COPD medication 4 weeks prior to visit 1.
* Current or ex-smokers with a smoking history of more than 10 pack years.

Exclusion criteria:

* Significant disease other than COPD.
* Clinically relevant abnormal baseline haematology, blood chemistry or creatinine \> x2 ULN will be excluded regardless of clinical condition. ( A repeat laboratory evaluation can be conducted if deemed necessary by the investigator.)
* Current documented diagnosis of asthma. For patients with allergic rhinitis or atopy, source documentation is required to verify that the patient does not have asthma
* A diagnosis of thyrotoxicosis
* A history of myocardial infarction within 6 months of screening visit.
* Life-threatening cardiac arrhythmia.
* Known active tuberculosis.
* Any malignancy unless free of disease for at least 5 years (patients with treated basal cell carcinoma or squamous cell skin cancers are allowed).
* A history of cystic fibrosis.
* Clinically relevant bronchiectasis.
* Patients with severe emphysema requiring endobronchial interventions within 6 months prior to screening
* A history of significant alcohol or drug abuse in the opinion of the investigator.
* Patients who have undergone thoracotomy with pulmonary resection
* Patients being treated with oral or patch ß-adrenergics.
* Patients being treated with oral corticosteroid medication at unstable doses
* Patients being treated with antibiotics for any reasons within 4 weeks of screening visit
* Patients being treated with PDE4 inhibitors within 3 months of screening visit
* Patients who have taken an investigational drug within one month or six half-lives
* Pregnant or nursing women.
* Women of childbearing potential not using a highly effective method of birth control.

Primary outcomes:
measure: Annualised Rate of Moderate to Severe COPD Exacerbations During the Actual Treatment Period.
timeFrame: From first in-take of study medication until 1 day after last in-take of study medication, up to 361 days
Secondary outcomes:
measure: Number of Patients With at Least One Moderate to Severe COPD Exacerbation During the Actual Treatment Period.
timeFrame: From first in-take of study medication until 1 day after last in-take of study medication, up to 361 days
measure: Annualised Rate of Exacerbations Leading to Hospitalisation During the Actual Treatment Period.
timeFrame: From first in-take of study medication until 1 day after last in-take of study medication, up to 361 days
measure: Number of Patients With at Least One COPD Exacerbation Leading to Hospitalisation During the Actual Treatment Period.
timeFrame: From first in-take of study medication until 1 day after last in-take of study medication, up to 361 days
measure: Number of Patients With All-cause Mortality Occurring During the Actual Treatment Period.
timeFrame: From first in-take of study medication until 1 day after last in-take of study medication, up to 361 days
Other outcomes:
Locations:
city: Andalusia
country: United States
facility: 1237.19.10039 Boehringer Ingelheim Investigational Site
state: Alabama
city: Birmingham
country: United States
facility: 1237.19.10009 Boehringer Ingelheim Investigational Site
state: Alabama
city: Florence
country: United States
facility: 1237.19.10077 Boehringer Ingelheim Investigational Site
state: Alabama
city: Jasper
country: United States
facility: 1237.19.10115 Boehringer Ingelheim Investigational Site
state: Alabama
city: Flagstaff
country: United States
facility: 1237.19.10069 Boehringer Ingelheim Investigational Site
state: Arizona
city: Peoria
country: United States
facility: 1237.19.10085 Boehringer Ingelheim Investigational Site
state: Arizona
city: Lincoln
country: United States
facility: 1237.19.10110 Boehringer Ingelheim Investigational Site
state: California
city: Los Angeles
country: United States
facility: 1237.19.10118 Boehringer Ingelheim Investigational Site
state: California
city: Poway
country: United States
facility: 1237.19.10074 Boehringer Ingelheim Investigational Site
state: California
city: Lafayette
country: United States
facility: 1237.19.10157 Boehringer Ingelheim Investigational Site
state: Colorado
city: Wheat Ridge
country: United States
facility: 1237.19.10142 Boehringer Ingelheim Investigational Site
state: Colorado
city: Norwalk
country: United States
facility: 1237.19.10133 Boehringer Ingelheim Investigational Site
state: Connecticut
city: Stamford
country: United States
facility: 1237.19.10093 Boehringer Ingelheim Investigational Site
state: Connecticut
city: Clearwater
country: United States
facility: 1237.19.10029 Boehringer Ingelheim Investigational Site
state: Florida
city: Clearwater
country: United States
facility: 1237.19.10106 Boehringer Ingelheim Investigational Site
state: Florida
city: Orlando
country: United States
facility: 1237.19.10020 Boehringer Ingelheim Investigational Site
state: Florida
city: Saint Petersburg
country: United States
facility: 1237.19.10000 Boehringer Ingelheim Investigational Site
state: Florida
city: Saint Petersburg
country: United States
facility: 1237.19.10135 Boehringer Ingelheim Investigational Site
state: Florida
city: Tamarac
country: United States
facility: 1237.19.10145 Boehringer Ingelheim Investigational Site
state: Florida
city: Tampa
country: United States
facility: 1237.19.10066 Boehringer Ingelheim Investigational Site
state: Florida
city: Winter Park
country: United States
facility: 1237.19.10032 Boehringer Ingelheim Investigational Site
state: Florida
city: Duluth
country: United States
facility: 1237.19.10080 Boehringer Ingelheim Investigational Site
state: Georgia
city: Gainesville
country: United States
facility: 1237.19.10011 Boehringer Ingelheim Investigational Site
state: Georgia
city: Lawrenceville
country: United States
facility: 1237.19.10112 Boehringer Ingelheim Investigational Site
state: Georgia
city: Eagle
country: United States
facility: 1237.19.10037 Boehringer Ingelheim Investigational Site
state: Idaho
city: O'Fallon
country: United States
facility: 1237.19.10130 Boehringer Ingelheim Investigational Site
state: Illinois
city: River Forest
country: United States
facility: 1237.19.10065 Boehringer Ingelheim Investigational Site
state: Illinois
city: Muncie
country: United States
facility: 1237.19.10122 Boehringer Ingelheim Investigational Site
state: Indiana
city: Topeka
country: United States
facility: 1237.19.10063 Boehringer Ingelheim Investigational Site
state: Kansas
city: Bowling Green
country: United States
facility: 1237.19.10048 Boehringer Ingelheim Investigational Site
state: Kentucky
city: Fort Mitchell
country: United States
facility: 1237.19.10108 Boehringer Ingelheim Investigational Site
state: Kentucky
city: New Orleans
country: United States
facility: 1237.19.10109 Boehringer Ingelheim Investigational Site
state: Louisiana
city: Opelousas
country: United States
facility: 1237.19.10095 Boehringer Ingelheim Investigational Site
state: Louisiana
city: Shreveport
country: United States
facility: 1237.19.10113 Boehringer Ingelheim Investigational Site
state: Louisiana
city: Shreveport
country: United States
facility: 1237.19.10139 Boehringer Ingelheim Investigational Site
state: Louisiana
city: Baltimore
country: United States
facility: 1237.19.10117 Boehringer Ingelheim Investigational Site
state: Maryland
city: Columbia
country: United States
facility: 1237.19.10083 Boehringer Ingelheim Investigational Site
state: Maryland
city: Hollywood
country: United States
facility: 1237.19.10072 Boehringer Ingelheim Investigational Site
state: Maryland
city: Fall River
country: United States
facility: 1237.19.10027 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: North Dartmouth
country: United States
facility: 1237.19.10138 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: Worcester
country: United States
facility: 1237.19.10103 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: Ann Arbor
country: United States
facility: 1237.19.10075 Boehringer Ingelheim Investigational Site
state: Michigan
city: Farmington Hills
country: United States
facility: 1237.19.10034 Boehringer Ingelheim Investigational Site
state: Michigan
city: Traverse City
country: United States
facility: 1237.19.10082 Boehringer Ingelheim Investigational Site
state: Michigan
city: Fridley
country: United States
facility: 1237.19.10043 Boehringer Ingelheim Investigational Site
state: Minnesota
city: Rochester
country: United States
facility: 1237.19.10096 Boehringer Ingelheim Investigational Site
state: Minnesota
city: Chesterfield
country: United States
facility: 1237.19.10031 Boehringer Ingelheim Investigational Site
state: Missouri
city: Saint Charles
country: United States
facility: 1237.19.10101 Boehringer Ingelheim Investigational Site
state: Missouri
city: Saint Louis
country: United States
facility: 1237.19.10051 Boehringer Ingelheim Investigational Site
state: Missouri
city: Saint Louis
country: United States
facility: 1237.19.10084 Boehringer Ingelheim Investigational Site
state: Missouri
city: Missoula
country: United States
facility: 1237.19.10097 Boehringer Ingelheim Investigational Site
state: Montana
city: Reno
country: United States
facility: 1237.19.10060 Boehringer Ingelheim Investigational Site
state: Nevada
city: Marlton
country: United States
facility: 1237.19.10081 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Brooklyn
country: United States
facility: 1237.19.10094 Boehringer Ingelheim Investigational Site
state: New York
city: Larchmont
country: United States
facility: 1237.19.10137 Boehringer Ingelheim Investigational Site
state: New York
city: Syracuse
country: United States
facility: 1237.19.10143 Boehringer Ingelheim Investigational Site
state: New York
city: Burlington
country: United States
facility: 1237.19.10035 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Calabash
country: United States
facility: 1237.19.10014 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Charlotte
country: United States
facility: 1237.19.10098 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Charlotte
country: United States
facility: 1237.19.10131 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Elizabeth City
country: United States
facility: 1237.19.10049 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Gastonia
country: United States
facility: 1237.19.10154 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Hickory
country: United States
facility: 1237.19.10104 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Huntersville
country: United States
facility: 1237.19.10087 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Shelby
country: United States
facility: 1237.19.10053 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Wilmington
country: United States
facility: 1237.19.10062 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Cincinnati
country: United States
facility: 1237.19.10008 Boehringer Ingelheim Investigational Site
state: Ohio
city: Cincinnati
country: United States
facility: 1237.19.10042 Boehringer Ingelheim Investigational Site
state: Ohio
city: Columbus
country: United States
facility: 1237.19.10127 Boehringer Ingelheim Investigational Site
state: Ohio
city: Dayton
country: United States
facility: 1237.19.10121 Boehringer Ingelheim Investigational Site
state: Ohio
city: Dayton
country: United States
facility: 1237.19.10148 Boehringer Ingelheim Investigational Site
state: Ohio
city: Delaware
country: United States
facility: 1237.19.10005 Boehringer Ingelheim Investigational Site
state: Ohio
city: Kettering
country: United States
facility: 1237.19.10147 Boehringer Ingelheim Investigational Site
state: Ohio
city: Toledo
country: United States
facility: 1237.19.10055 Boehringer Ingelheim Investigational Site
state: Ohio
city: Tulsa
country: United States
facility: 1237.19.10146 Boehringer Ingelheim Investigational Site
state: Oklahoma
city: Medford
country: United States
facility: 1237.19.10021 Boehringer Ingelheim Investigational Site
state: Oregon
city: Erie
country: United States
facility: 1237.19.10129 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Oaks
country: United States
facility: 1237.19.10140 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Philadelphia
country: United States
facility: 1237.19.10003 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Philadelphia
country: United States
facility: 1237.19.10019 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Pittsburgh
country: United States
facility: 1237.19.10006 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Pittsburgh
country: United States
facility: 1237.19.10136 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Pittsburgh
country: United States
facility: 1237.19.10151 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: East Providence
country: United States
facility: 1237.19.10041 Boehringer Ingelheim Investigational Site
state: Rhode Island
city: Johnston
country: United States
facility: 1237.19.10126 Boehringer Ingelheim Investigational Site
state: Rhode Island
city: Charleston
country: United States
facility: 1237.19.10054 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Columbia
country: United States
facility: 1237.19.10086 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Easley
country: United States
facility: 1237.19.10058 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Gaffney
country: United States
facility: 1237.19.10023 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Gaffney
country: United States
facility: 1237.19.10030 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Greenville
country: United States
facility: 1237.19.10024 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Greenville
country: United States
facility: 1237.19.10128 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Indian Land
country: United States
facility: 1237.19.10099 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Mount Pleasant
country: United States
facility: 1237.19.10144 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Myrtle Beach
country: United States
facility: 1237.19.10071 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Rock Hill
country: United States
facility: 1237.19.10025 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Spartanburg
country: United States
facility: 1237.19.10033 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Spartanburg
country: United States
facility: 1237.19.10036 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Union
country: United States
facility: 1237.19.10010 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Rapid City
country: United States
facility: 1237.19.10007 Boehringer Ingelheim Investigational Site
state: South Dakota
city: Boerne
country: United States
facility: 1237.19.10070 Boehringer Ingelheim Investigational Site
state: Texas
city: Corsicana
country: United States
facility: 1237.19.10107 Boehringer Ingelheim Investigational Site
state: Texas
city: Fort Worth
country: United States
facility: 1237.19.10153 Boehringer Ingelheim Investigational Site
state: Texas
city: Houston
country: United States
facility: 1237.19.10047 Boehringer Ingelheim Investigational Site
state: Texas
city: Killeen
country: United States
facility: 1237.19.10111 Boehringer Ingelheim Investigational Site
state: Texas
city: Kingwood
country: United States
facility: 1237.19.10059 Boehringer Ingelheim Investigational Site
state: Texas
city: McKinney
country: United States
facility: 1237.19.10061 Boehringer Ingelheim Investigational Site
state: Texas
city: San Antonio
country: United States
facility: 1237.19.10050 Boehringer Ingelheim Investigational Site
state: Texas
city: Abingdon
country: United States
facility: 1237.19.10091 Boehringer Ingelheim Investigational Site
state: Virginia
city: Lynchburg
country: United States
facility: 1237.19.10076 Boehringer Ingelheim Investigational Site
state: Virginia
city: Richmond
country: United States
facility: 1237.19.10040 Boehringer Ingelheim Investigational Site
state: Virginia
city: Richmond
country: United States
facility: 1237.19.10089 Boehringer Ingelheim Investigational Site
state: Virginia
city: Everett
country: United States
facility: 1237.19.10123 Boehringer Ingelheim Investigational Site
state: Washington
city: Spokane
country: United States
facility: 1237.19.10120 Boehringer Ingelheim Investigational Site
state: Washington
city: Tacoma
country: United States
facility: 1237.19.10092 Boehringer Ingelheim Investigational Site
state: Washington
city: Morgantown
country: United States
facility: 1237.19.10001 Boehringer Ingelheim Investigational Site
state: West Virginia
city: West Allis
country: United States
facility: 1237.19.10016 Boehringer Ingelheim Investigational Site
state: Wisconsin
city: Bahía Blanca
country: Argentina
facility: 1237.19.54015 Boehringer Ingelheim Investigational Site
city: Berazategui
country: Argentina
facility: 1237.19.54014 Boehringer Ingelheim Investigational Site
city: Capital Federal
country: Argentina
facility: 1237.19.54003 Boehringer Ingelheim Investigational Site
city: Capital Federal
country: Argentina
facility: 1237.19.54004 Boehringer Ingelheim Investigational Site
city: Capital Federal
country: Argentina
facility: 1237.19.54007 Boehringer Ingelheim Investigational Site
city: Ciudad de Buenos Aires
country: Argentina
facility: 1237.19.54011 Boehringer Ingelheim Investigational Site
city: Ciudad de Buenos Aires
country: Argentina
facility: 1237.19.54018 Boehringer Ingelheim Investigational Site
city: La Plata
country: Argentina
facility: 1237.19.54010 Boehringer Ingelheim Investigational Site
city: Mar del Plata
country: Argentina
facility: 1237.19.54012 Boehringer Ingelheim Investigational Site
city: Mar del Plata
country: Argentina
facility: 1237.19.54017 Boehringer Ingelheim Investigational Site
city: Mar del Plata
country: Argentina
facility: 1237.19.54019 Boehringer Ingelheim Investigational Site
city: Mendoza
country: Argentina
facility: 1237.19.54005 Boehringer Ingelheim Investigational Site
city: Quilmes
country: Argentina
facility: 1237.19.54006 Boehringer Ingelheim Investigational Site
city: Rosario
country: Argentina
facility: 1237.19.54013 Boehringer Ingelheim Investigational Site
city: San Isidro
country: Argentina
facility: 1237.19.54016 Boehringer Ingelheim Investigational Site
city: San Miguel de Tucuman
country: Argentina
facility: 1237.19.54002 Boehringer Ingelheim Investigational Site
city: Tucumán
country: Argentina
facility: 1237.19.54001 Boehringer Ingelheim Investigational Site
city: Campbelltown
country: Australia
facility: 1237.19.61012 Boehringer Ingelheim Investigational Site
state: New South Wales
city: Kogarah
country: Australia
facility: 1237.19.61011 Boehringer Ingelheim Investigational Site
state: New South Wales
city: Randwick
country: Australia
facility: 1237.19.61008 Boehringer Ingelheim Investigational Site
state: New South Wales
city: Cairns
country: Australia
facility: 1237.19.61010 Boehringer Ingelheim Investigational Site
state: Queensland
city: Chermside
country: Australia
facility: 1237.19.61006 Boehringer Ingelheim Investigational Site
state: Queensland
city: Daw Park
country: Australia
facility: 1237.19.61001 Boehringer Ingelheim Investigational Site
state: South Australia
city: Kent Town
country: Australia
facility: 1237.19.61002 Boehringer Ingelheim Investigational Site
state: South Australia
city: Woodville
country: Australia
facility: 1237.19.61007 Boehringer Ingelheim Investigational Site
state: South Australia
city: Box Hill
country: Australia
facility: 1237.19.61013 Boehringer Ingelheim Investigational Site
state: Victoria
city: Melbourne
country: Australia
facility: 1237.19.61003 Boehringer Ingelheim Investigational Site
state: Victoria
city: Parkville
country: Australia
facility: 1237.19.61009 Boehringer Ingelheim Investigational Site
state: Victoria
city: Murdoch
country: Australia
facility: 1237.19.61004 Boehringer Ingelheim Investigational Site
state: Western Australia
city: Feldbach
country: Austria
facility: 1237.19.43006 Boehringer Ingelheim Investigational Site
city: Graz
country: Austria
facility: 1237.19.43004 Boehringer Ingelheim Investigational Site
city: Leoben
country: Austria
facility: 1237.19.43003 Boehringer Ingelheim Investigational Site
city: Linz
country: Austria
facility: 1237.19.43001 Boehringer Ingelheim Investigational Site
city: Ryazan
country: Austria
facility: 1237.19.70001 Boehringer Ingelheim Investigational Site
city: Salzburg
country: Austria
facility: 1237.19.43005 Boehringer Ingelheim Investigational Site
city: Wien
country: Austria
facility: 1237.19.43002 Boehringer Ingelheim Investigational Site
city: Brussels
country: Belgium
facility: 1237.19.32007 Boehringer Ingelheim Investigational Site
city: Brussel
country: Belgium
facility: 1237.19.32001 Boehringer Ingelheim Investigational Site
city: Gilly
country: Belgium
facility: 1237.19.32006 Boehringer Ingelheim Investigational Site
city: Jambes
country: Belgium
facility: 1237.19.32004 Boehringer Ingelheim Investigational Site
city: Lebbeke
country: Belgium
facility: 1237.19.32003 Boehringer Ingelheim Investigational Site
city: Turnhout
country: Belgium
facility: 1237.19.32002 Boehringer Ingelheim Investigational Site
city: Zichem
country: Belgium
facility: 1237.19.32005 Boehringer Ingelheim Investigational Site
city: Belo Horizonte
country: Brazil
facility: 1237.19.55007 Boehringer Ingelheim Investigational Site
city: Botucatu
country: Brazil
facility: 1237.19.55013 Boehringer Ingelheim Investigational Site
city: Goiania
country: Brazil
facility: 1237.19.55011 Boehringer Ingelheim Investigational Site
city: Porto Alegre
country: Brazil
facility: 1237.19.55002 Boehringer Ingelheim Investigational Site
city: Porto Alegre
country: Brazil
facility: 1237.19.55006 Boehringer Ingelheim Investigational Site
city: Porto Alegre
country: Brazil
facility: 1237.19.55010 Boehringer Ingelheim Investigational Site
city: Porto Alegre
country: Brazil
facility: 1237.19.55012 Boehringer Ingelheim Investigational Site
city: Santo Andre
country: Brazil
facility: 1237.19.55014 Boehringer Ingelheim Investigational Site
city: Sao Paulo
country: Brazil
facility: 1237.19.55005 Boehringer Ingelheim Investigational Site
city: Sao Paulo
country: Brazil
facility: 1237.19.55008 Boehringer Ingelheim Investigational Site
city: São Paulo
country: Brazil
facility: 1237.19.55001 Boehringer Ingelheim Investigational Site
city: Vitoria
country: Brazil
facility: 1237.19.55009 Boehringer Ingelheim Investigational Site
city: Plovdiv
country: Bulgaria
facility: 1237.19.35905 Boehringer Ingelheim Investigational Site
city: Ruse
country: Bulgaria
facility: 1237.19.35902 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 1237.19.35903 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 1237.19.35904 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 1237.19.35906 Boehringer Ingelheim Investigational Site
city: Troyan
country: Bulgaria
facility: 1237.19.35907 Boehringer Ingelheim Investigational Site
city: Varna
country: Bulgaria
facility: 1237.19.35901 Boehringer Ingelheim Investigational Site
city: Vidin
country: Bulgaria
facility: 1237.19.35908 Boehringer Ingelheim Investigational Site
city: Calgary
country: Canada
facility: 1237.19.20011 Boehringer Ingelheim Investigational Site
state: Alberta
city: Calgary
country: Canada
facility: 1237.19.20020 Boehringer Ingelheim Investigational Site
state: Alberta
city: Edmonton
country: Canada
facility: 1237.19.20016 Boehringer Ingelheim Investigational Site
state: Alberta
city: Edmonton
country: Canada
facility: 1237.19.20025 Boehringer Ingelheim Investigational Site
state: Alberta
city: Coquitlam
country: Canada
facility: 1237.19.20035 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Kelowna
country: Canada
facility: 1237.19.20034 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Maple Ridge
country: Canada
facility: 1237.19.20041 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Vancouver
country: Canada
facility: 1237.19.20010 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Vancouver
country: Canada
facility: 1237.19.20033 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Vancouver
country: Canada
facility: 1237.19.20036 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Winnipeg
country: Canada
facility: 1237.19.20015 Boehringer Ingelheim Investigational Site
state: Manitoba
city: Moncton
country: Canada
facility: 1237.19.20021 Boehringer Ingelheim Investigational Site
state: New Brunswick
city: Saint John
country: Canada
facility: 1237.19.20006 Boehringer Ingelheim Investigational Site
state: New Brunswick
city: Saint John¿s
country: Canada
facility: 1237.19.20013 Boehringer Ingelheim Investigational Site
state: Newfoundland and Labrador
city: Burlington
country: Canada
facility: 1237.19.20018 Boehringer Ingelheim Investigational Site
state: Ontario
city: Corunna
country: Canada
facility: 1237.19.20029 Boehringer Ingelheim Investigational Site
state: Ontario
city: Courtice
country: Canada
facility: 1237.19.20009 Boehringer Ingelheim Investigational Site
state: Ontario
city: Grimsby
country: Canada
facility: 1237.19.20019 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 1237.19.20017 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 1237.19.20026 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 1237.19.20038 Boehringer Ingelheim Investigational Site
state: Ontario
city: London
country: Canada
facility: 1237.19.20022 Boehringer Ingelheim Investigational Site
state: Ontario
city: Ottawa
country: Canada
facility: 1237.19.20040 Boehringer Ingelheim Investigational Site
state: Ontario
city: Sarnia
country: Canada
facility: 1237.19.20030 Boehringer Ingelheim Investigational Site
state: Ontario
city: Toronto
country: Canada
facility: 1237.19.20005 Boehringer Ingelheim Investigational Site
state: Ontario
city: Toronto
country: Canada
facility: 1237.19.20037 Boehringer Ingelheim Investigational Site
state: Ontario
city: Waterloo
country: Canada
facility: 1237.19.20012 Boehringer Ingelheim Investigational Site
state: Ontario
city: Windsor
country: Canada
facility: 1237.19.20007 Boehringer Ingelheim Investigational Site
state: Ontario
city: Longueuil
country: Canada
facility: 1237.19.20004 Boehringer Ingelheim Investigational Site
state: Quebec
city: Montreal
country: Canada
facility: 1237.19.20032 Boehringer Ingelheim Investigational Site
state: Quebec
city: Point Claire
country: Canada
facility: 1237.19.20008 Boehringer Ingelheim Investigational Site
state: Quebec
city: St-Charles-Borromée
country: Canada
facility: 1237.19.20031 Boehringer Ingelheim Investigational Site
state: Quebec
city: Ste-Foy
country: Canada
facility: 1237.19.20023 Boehringer Ingelheim Investigational Site
state: Quebec
city: Trois-Rivieres
country: Canada
facility: 1237.19.20039 Boehringer Ingelheim Investigational Site
state: Quebec
city: Victoriaville
country: Canada
facility: 1237.19.20003 Boehringer Ingelheim Investigational Site
state: Quebec
city: Saskatoon
country: Canada
facility: 1237.19.20002 Boehringer Ingelheim Investigational Site
state: Saskatchewan
city: Saskatoon
country: Canada
facility: 1237.19.20027 Boehringer Ingelheim Investigational Site
state: Saskatchewan
city: Quebec
country: Canada
facility: 1237.19.20014 Boehringer Ingelheim Investigational Site
city: Quillota
country: Chile
facility: 1237.19.53004 Boehringer Ingelheim Investigational Site
city: San Miguel
country: Chile
facility: 1237.19.53003 Boehringer Ingelheim Investigational Site
city: Santiago de Chile
country: Chile
facility: 1237.19.53002 Boehringer Ingelheim Investigational Site
city: Bogotá
country: Colombia
facility: 1237.19.57002 Boehringer Ingelheim Investigational Site
city: Bogotá
country: Colombia
facility: 1237.19.57004 Boehringer Ingelheim Investigational Site
city: Bogotá
country: Colombia
facility: 1237.19.57005 Boehringer Ingelheim Investigational Site
city: Cali
country: Colombia
facility: 1237.19.57003 Boehringer Ingelheim Investigational Site
city: Medellín
country: Colombia
facility: 1237.19.57006 Boehringer Ingelheim Investigational Site
city: Rijeka
country: Croatia
facility: 1237.19.38501 Boehringer Ingelheim Investigational Site
city: Zagreb
country: Croatia
facility: 1237.19.38502 Boehringer Ingelheim Investigational Site
city: Zagreb
country: Croatia
facility: 1237.19.38503 Boehringer Ingelheim Investigational Site
city: Beroun
country: Czechia
facility: 1237.19.42001 Boehringer Ingelheim Investigational Site
city: Cesky Krumlov
country: Czechia
facility: 1237.19.42010 Boehringer Ingelheim Investigational Site
city: Hradec Kralove
country: Czechia
facility: 1237.19.42004 Boehringer Ingelheim Investigational Site
city: Jindrichuv Hradec
country: Czechia
facility: 1237.19.42002 Boehringer Ingelheim Investigational Site
city: Krnov
country: Czechia
facility: 1237.19.42006 Boehringer Ingelheim Investigational Site
city: Liberec
country: Czechia
facility: 1237.19.42007 Boehringer Ingelheim Investigational Site
city: Melnik
country: Czechia
facility: 1237.19.42003 Boehringer Ingelheim Investigational Site
city: Prague 8
country: Czechia
facility: 1237.19.42005 Boehringer Ingelheim Investigational Site
city: Praha
country: Czechia
facility: 1237.19.42008 Boehringer Ingelheim Investigational Site
city: Varnsdorf
country: Czechia
facility: 1237.19.42009 Boehringer Ingelheim Investigational Site
city: Aarhus
country: Denmark
facility: 1237.19.45007 Boehringer Ingelheim Investigational Site
city: Holstebro
country: Denmark
facility: 1237.19.45006 Boehringer Ingelheim Investigational Site
city: Hvidovre
country: Denmark
facility: 1237.19.45002 Boehringer Ingelheim Investigational Site
city: Kolding
country: Denmark
facility: 1237.19.45005 Boehringer Ingelheim Investigational Site
city: Odense
country: Denmark
facility: 1237.19.45001 Boehringer Ingelheim Investigational Site
city: Roskilde
country: Denmark
facility: 1237.19.45008 Boehringer Ingelheim Investigational Site
city: Vaerløse
country: Denmark
facility: 1237.19.45003 Boehringer Ingelheim Investigational Site
city: Ålborg
country: Denmark
facility: 1237.19.45004 Boehringer Ingelheim Investigational Site
city: Helsinki
country: Finland
facility: 1237.19.35804 Boehringer Ingelheim Investigational Site
city: Oulu
country: Finland
facility: 1237.19.35805 Boehringer Ingelheim Investigational Site
city: Turku
country: Finland
facility: 1237.19.35801 Boehringer Ingelheim Investigational Site
city: Turku
country: Finland
facility: 1237.19.35803 Boehringer Ingelheim Investigational Site
city: Cannes
country: France
facility: 1237.19.33016 Boehringer Ingelheim Investigational Site
city: La Tronche
country: France
facility: 1237.19.33014 Boehringer Ingelheim Investigational Site
city: MARSEILLE Cedex 08
country: France
facility: 1237.19.33020 Boehringer Ingelheim Investigational Site
city: Marseille
country: France
facility: 1237.19.33013 Boehringer Ingelheim Investigational Site
city: Montpellier cedex 5
country: France
facility: 1237.19.33003 Boehringer Ingelheim Investigational Site
city: Nantes Cedex 01
country: France
facility: 1237.19.33024 Boehringer Ingelheim Investigational Site
city: Nice
country: France
facility: 1237.19.33017 Boehringer Ingelheim Investigational Site
city: Nîmes cedex 9
country: France
facility: 1237.19.33018 Boehringer Ingelheim Investigational Site
city: Nîmes
country: France
facility: 1237.19.33019 Boehringer Ingelheim Investigational Site
city: Paris
country: France
facility: 1237.19.33001 Boehringer Ingelheim Investigational Site
city: Pessac
country: France
facility: 1237.19.33002 Boehringer Ingelheim Investigational Site
city: Reims
country: France
facility: 1237.19.33006 Boehringer Ingelheim Investigational Site
city: Rennes Cedex 9
country: France
facility: 1237.19.33021 Boehringer Ingelheim Investigational Site
city: Saint Laurent du Var
country: France
facility: 1237.19.33005 Boehringer Ingelheim Investigational Site
city: Saint Pierre - La Réunion
country: France
facility: 1237.19.33012 Boehringer Ingelheim Investigational Site
city: Strasbourg
country: France
facility: 1237.19.33022 Boehringer Ingelheim Investigational Site
city: Toulouse cedex 9
country: France
facility: 1237.19.33007 Boehringer Ingelheim Investigational Site
city: TOURS Cedex 9
country: France
facility: 1237.19.33023 Boehringer Ingelheim Investigational Site
city: Vieux Condé
country: France
facility: 1237.19.33010 Boehringer Ingelheim Investigational Site
city: Ahlen
country: Germany
facility: 1237.19.49041 Boehringer Ingelheim Investigational Site
city: Aschaffenburg
country: Germany
facility: 1237.19.49004 Boehringer Ingelheim Investigational Site
city: Augsburg
country: Germany
facility: 1237.19.49059 Boehringer Ingelheim Investigational Site
city: Bad Wörishofen
country: Germany
facility: 1237.19.49042 Boehringer Ingelheim Investigational Site
city: Bamberg
country: Germany
facility: 1237.19.49072 Boehringer Ingelheim Investigational Site
city: Bergisch Gladbach
country: Germany
facility: 1237.19.49024 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49009 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49011 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49018 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49025 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49026 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49029 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49035 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49043 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49058 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1237.19.49065 Boehringer Ingelheim Investigational Site
city: Bielefeld
country: Germany
facility: 1237.19.49076 Boehringer Ingelheim Investigational Site
city: Bochum
country: Germany
facility: 1237.19.49064 Boehringer Ingelheim Investigational Site
city: Bonn
country: Germany
facility: 1237.19.49048 Boehringer Ingelheim Investigational Site
city: Düren
country: Germany
facility: 1237.19.49002 Boehringer Ingelheim Investigational Site
city: Essen
country: Germany
facility: 1237.19.49012 Boehringer Ingelheim Investigational Site
city: Frankfurt
country: Germany
facility: 1237.19.49017 Boehringer Ingelheim Investigational Site
city: Frankfurt
country: Germany
facility: 1237.19.49019 Boehringer Ingelheim Investigational Site
city: Frankfurt
country: Germany
facility: 1237.19.49052 Boehringer Ingelheim Investigational Site
city: Frankfurt
country: Germany
facility: 1237.19.49062 Boehringer Ingelheim Investigational Site
city: Fulda
country: Germany
facility: 1237.19.49044 Boehringer Ingelheim Investigational Site
city: Fürstenwalde
country: Germany
facility: 1237.19.49057 Boehringer Ingelheim Investigational Site
city: Großhansdorf
country: Germany
facility: 1237.19.49001 Boehringer Ingelheim Investigational Site
city: Gütersloh
country: Germany
facility: 1237.19.49008 Boehringer Ingelheim Investigational Site
city: Halle/Saale
country: Germany
facility: 1237.19.49028 Boehringer Ingelheim Investigational Site
city: Hamburg
country: Germany
facility: 1237.19.49038 Boehringer Ingelheim Investigational Site
city: Hannover
country: Germany
facility: 1237.19.49055 Boehringer Ingelheim Investigational Site
city: Hannover
country: Germany
facility: 1237.19.49077 Boehringer Ingelheim Investigational Site
city: Heidelberg
country: Germany
facility: 1237.19.49022 Boehringer Ingelheim Investigational Site
city: Höchstädt
country: Germany
facility: 1237.19.49056 Boehringer Ingelheim Investigational Site
city: Kiel
country: Germany
facility: 1237.19.49049 Boehringer Ingelheim Investigational Site
city: Koblenz
country: Germany
facility: 1237.19.49005 Boehringer Ingelheim Investigational Site
city: Köln
country: Germany
facility: 1237.19.49034 Boehringer Ingelheim Investigational Site
city: Landsberg am Lech
country: Germany
facility: 1237.19.49073 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 1237.19.49003 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 1237.19.49007 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 1237.19.49030 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 1237.19.49061 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 1237.19.49063 Boehringer Ingelheim Investigational Site
city: Leipzig
country: Germany
facility: 1237.19.49070 Boehringer Ingelheim Investigational Site
city: Leverkusen
country: Germany
facility: 1237.19.49010 Boehringer Ingelheim Investigational Site
city: Lübeck
country: Germany
facility: 1237.19.49037 Boehringer Ingelheim Investigational Site
city: Mannheim
country: Germany
facility: 1237.19.49016 Boehringer Ingelheim Investigational Site
city: Mannheim
country: Germany
facility: 1237.19.49046 Boehringer Ingelheim Investigational Site
city: Marburg
country: Germany
facility: 1237.19.49036 Boehringer Ingelheim Investigational Site
city: Minden
country: Germany
facility: 1237.19.49054 Boehringer Ingelheim Investigational Site
city: München
country: Germany
facility: 1237.19.49006 Boehringer Ingelheim Investigational Site
city: München
country: Germany
facility: 1237.19.49013 Boehringer Ingelheim Investigational Site
city: Paderborn
country: Germany
facility: 1237.19.49047 Boehringer Ingelheim Investigational Site
city: Peine
country: Germany
facility: 1237.19.49014 Boehringer Ingelheim Investigational Site
city: Potsdam
country: Germany
facility: 1237.19.49074 Boehringer Ingelheim Investigational Site
city: Radebeul
country: Germany
facility: 1237.19.49045 Boehringer Ingelheim Investigational Site
city: Rheine
country: Germany
facility: 1237.19.49053 Boehringer Ingelheim Investigational Site
city: Rüdersdorf
country: Germany
facility: 1237.19.49060 Boehringer Ingelheim Investigational Site
city: Solingen
country: Germany
facility: 1237.19.49050 Boehringer Ingelheim Investigational Site
city: Teuchern
country: Germany
facility: 1237.19.49032 Boehringer Ingelheim Investigational Site
city: Wardenburg
country: Germany
facility: 1237.19.49051 Boehringer Ingelheim Investigational Site
city: Wiesloch
country: Germany
facility: 1237.19.49040 Boehringer Ingelheim Investigational Site
city: Witten
country: Germany
facility: 1237.19.49023 Boehringer Ingelheim Investigational Site
city: Athens
country: Greece
facility: 1237.19.30003 Boehringer Ingelheim Investigational Site
city: Athens
country: Greece
facility: 1237.19.30007 Boehringer Ingelheim Investigational Site
city: Athens
country: Greece
facility: 1237.19.30008 Boehringer Ingelheim Investigational Site
city: Heraklion
country: Greece
facility: 1237.19.30004 Boehringer Ingelheim Investigational Site
city: Nafplio
country: Greece
facility: 1237.19.30002 Boehringer Ingelheim Investigational Site
city: Serres
country: Greece
facility: 1237.19.30005 Boehringer Ingelheim Investigational Site
city: Thessaloniki
country: Greece
facility: 1237.19.30001 Boehringer Ingelheim Investigational Site
city: Thessaloniki
country: Greece
facility: 1237.19.30006 Boehringer Ingelheim Investigational Site
city: Guatemala
country: Guatemala
facility: 1237.19.50201 Boehringer Ingelheim Investigational Site
city: Guatemala
country: Guatemala
facility: 1237.19.50202 Boehringer Ingelheim Investigational Site
city: Guatemala
country: Guatemala
facility: 1237.19.50203 Boehringer Ingelheim Investigational Site
city: Guatemala
country: Guatemala
facility: 1237.19.50204 Boehringer Ingelheim Investigational Site
city: Guatemala
country: Guatemala
facility: 1237.19.50205 Boehringer Ingelheim Investigational Site
city: Hong Kong
country: Hong Kong
facility: 1237.19.85201 Boehringer Ingelheim Investigational Site
city: Hong Kong
country: Hong Kong
facility: 1237.19.85202 Boehringer Ingelheim Investigational Site
city: Hong Kong
country: Hong Kong
facility: 1237.19.85203 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 1237.19.36006 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 1237.19.36012 Boehringer Ingelheim Investigational Site
city: Debrecen
country: Hungary
facility: 1237.19.36005 Boehringer Ingelheim Investigational Site
city: Debrecen
country: Hungary
facility: 1237.19.36015 Boehringer Ingelheim Investigational Site
city: Edeleny
country: Hungary
facility: 1237.19.36008 Boehringer Ingelheim Investigational Site
city: Farkasgyepu
country: Hungary
facility: 1237.19.36011 Boehringer Ingelheim Investigational Site
city: Godollo
country: Hungary
facility: 1237.19.36002 Boehringer Ingelheim Investigational Site
city: Hajdunanas
country: Hungary
facility: 1237.19.36014 Boehringer Ingelheim Investigational Site
city: Kapuvar
country: Hungary
facility: 1237.19.36013 Boehringer Ingelheim Investigational Site
city: Komarom
country: Hungary
facility: 1237.19.36009 Boehringer Ingelheim Investigational Site
city: Nyiregyhaza
country: Hungary
facility: 1237.19.36007 Boehringer Ingelheim Investigational Site
city: Pecs
country: Hungary
facility: 1237.19.36003 Boehringer Ingelheim Investigational Site
city: Pecs
country: Hungary
facility: 1237.19.36004 Boehringer Ingelheim Investigational Site
city: Szazhalombatta
country: Hungary
facility: 1237.19.36010 Boehringer Ingelheim Investigational Site
city: Szeged
country: Hungary
facility: 1237.19.36001 Boehringer Ingelheim Investigational Site
city: Ahmadabad
country: India
facility: 1237.19.91016 Boehringer Ingelheim Investigational Site
city: Ahmedabad
country: India
facility: 1237.19.91013 Boehringer Ingelheim Investigational Site
city: Ahmedabad
country: India
facility: 1237.19.91040 Boehringer Ingelheim Investigational Site
city: Bangalore
country: India
facility: 1237.19.91032 Boehringer Ingelheim Investigational Site
city: Coimbatore
country: India
facility: 1237.19.91004 Boehringer Ingelheim Investigational Site
city: Gurgaon
country: India
facility: 1237.19.91033 Boehringer Ingelheim Investigational Site
city: Hyderabad
country: India
facility: 1237.19.91005 Boehringer Ingelheim Investigational Site
city: Hyderabad
country: India
facility: 1237.19.91019 Boehringer Ingelheim Investigational Site
city: Hyderabad
country: India
facility: 1237.19.91020 Boehringer Ingelheim Investigational Site
city: Hyderabad
country: India
facility: 1237.19.91025 Boehringer Ingelheim Investigational Site
city: Jaipur
country: India
facility: 1237.19.91006 Boehringer Ingelheim Investigational Site
city: Jaipur
country: India
facility: 1237.19.91042 Boehringer Ingelheim Investigational Site
city: Jaipur
country: India
facility: 1237.19.91044 Boehringer Ingelheim Investigational Site
city: Karamsad
country: India
facility: 1237.19.91026 Boehringer Ingelheim Investigational Site
city: Kolkata
country: India
facility: 1237.19.91034 Boehringer Ingelheim Investigational Site
city: Ludhiana
country: India
facility: 1237.19.91010 Boehringer Ingelheim Investigational Site
city: Madurai
country: India
facility: 1237.19.91007 Boehringer Ingelheim Investigational Site
city: Mysore
country: India
facility: 1237.19.91014 Boehringer Ingelheim Investigational Site
city: Mysore
country: India
facility: 1237.19.91021 Boehringer Ingelheim Investigational Site
city: Nagpur
country: India
facility: 1237.19.91001 Boehringer Ingelheim Investigational Site
city: Nagpur
country: India
facility: 1237.19.91002 Boehringer Ingelheim Investigational Site
city: Nagpur
country: India
facility: 1237.19.91003 Boehringer Ingelheim Investigational Site
city: New Delhi
country: India
facility: 1237.19.91027 Boehringer Ingelheim Investigational Site
city: Panjim
country: India
facility: 1237.19.91024 Boehringer Ingelheim Investigational Site
city: Pune
country: India
facility: 1237.19.91023 Boehringer Ingelheim Investigational Site
city: Pune
country: India
facility: 1237.19.91035 Boehringer Ingelheim Investigational Site
city: Vellore
country: India
facility: 1237.19.91008 Boehringer Ingelheim Investigational Site
city: Vishakhapatnam
country: India
facility: 1237.19.91028 Boehringer Ingelheim Investigational Site
city: Dublin 24
country: Ireland
facility: 1237.19.35301 Boehringer Ingelheim Investigational Site
city: Wilton
country: Ireland
facility: 1237.19.35302 Boehringer Ingelheim Investigational Site
city: Cittadella (PD)
country: Italy
facility: 1237.19.39011 Boehringer Ingelheim Investigational Site
city: Ferrara
country: Italy
facility: 1237.19.39014 Boehringer Ingelheim Investigational Site
city: Messina
country: Italy
facility: 1237.19.39010 Boehringer Ingelheim Investigational Site
city: Milano
country: Italy
facility: 1237.19.39002 Boehringer Ingelheim Investigational Site
city: Milano
country: Italy
facility: 1237.19.39016 Boehringer Ingelheim Investigational Site
city: Milano
country: Italy
facility: 1237.19.39023 Boehringer Ingelheim Investigational Site
city: Monza
country: Italy
facility: 1237.19.39015 Boehringer Ingelheim Investigational Site
city: Padova
country: Italy
facility: 1237.19.39025 Boehringer Ingelheim Investigational Site
city: Palermo
country: Italy
facility: 1237.19.39024 Boehringer Ingelheim Investigational Site
city: Parma
country: Italy
facility: 1237.19.39006 Boehringer Ingelheim Investigational Site
city: Pavia
country: Italy
facility: 1237.19.39005 Boehringer Ingelheim Investigational Site
city: Perugia
country: Italy
facility: 1237.19.39007 Boehringer Ingelheim Investigational Site
city: Piacenza
country: Italy
facility: 1237.19.39008 Boehringer Ingelheim Investigational Site
city: Pisa
country: Italy
facility: 1237.19.39001 Boehringer Ingelheim Investigational Site
city: Pisa
country: Italy
facility: 1237.19.39020 Boehringer Ingelheim Investigational Site
city: Pordenone
country: Italy
facility: 1237.19.39013 Boehringer Ingelheim Investigational Site
city: Roma
country: Italy
facility: 1237.19.39003 Boehringer Ingelheim Investigational Site
city: Roma
country: Italy
facility: 1237.19.39004 Boehringer Ingelheim Investigational Site
city: Roma
country: Italy
facility: 1237.19.39012 Boehringer Ingelheim Investigational Site
city: San Pietro Vernotico (BR)
country: Italy
facility: 1237.19.39021 Boehringer Ingelheim Investigational Site
city: Sassari
country: Italy
facility: 1237.19.39017 Boehringer Ingelheim Investigational Site
city: Scafati (SA)
country: Italy
facility: 1237.19.39019 Boehringer Ingelheim Investigational Site
city: Aichi, Komaki
country: Japan
facility: 1237.19.81072 Boehringer Ingelheim Investigational Site
city: Aichi, Nagoya
country: Japan
facility: 1237.19.81070 Boehringer Ingelheim Investigational Site
city: Aichi, Nagoya
country: Japan
facility: 1237.19.81073 Boehringer Ingelheim Investigational Site
city: Aichi, Nagoya
country: Japan
facility: 1237.19.81074 Boehringer Ingelheim Investigational Site
city: Aichi, Obu
country: Japan
facility: 1237.19.81071 Boehringer Ingelheim Investigational Site
city: Aichi, Seto
country: Japan
facility: 1237.19.81069 Boehringer Ingelheim Investigational Site
city: Chiba, Chiba
country: Japan
facility: 1237.19.81030 Boehringer Ingelheim Investigational Site
city: Chiba, Kamogawa
country: Japan
facility: 1237.19.81031 Boehringer Ingelheim Investigational Site
city: Fukui, Fukui
country: Japan
facility: 1237.19.81061 Boehringer Ingelheim Investigational Site
city: Fukuoka, Fukuoka
country: Japan
facility: 1237.19.81116 Boehringer Ingelheim Investigational Site
city: Fukuoka, Kitakyushu-city
country: Japan
facility: 1237.19.81112 Boehringer Ingelheim Investigational Site
city: Fukuoka, Koga
country: Japan
facility: 1237.19.81113 Boehringer Ingelheim Investigational Site
city: Fukuoka, Kurume
country: Japan
facility: 1237.19.81111 Boehringer Ingelheim Investigational Site
city: Fukuoka, Yanagawa
country: Japan
facility: 1237.19.81114 Boehringer Ingelheim Investigational Site
city: Fukuoka, Yukuhashi
country: Japan
facility: 1237.19.81115 Boehringer Ingelheim Investigational Site
city: Fukushima, Fukushima
country: Japan
facility: 1237.19.81022 Boehringer Ingelheim Investigational Site
city: Gifu, Mizunami
country: Japan
facility: 1237.19.81066 Boehringer Ingelheim Investigational Site
city: Gifu, Ogaki
country: Japan
facility: 1237.19.81065 Boehringer Ingelheim Investigational Site
city: Gunma, Fujioka
country: Japan
facility: 1237.19.81025 Boehringer Ingelheim Investigational Site
city: Gunma, Maebashi
country: Japan
facility: 1237.19.81027 Boehringer Ingelheim Investigational Site
city: Gunma, Takasaki
country: Japan
facility: 1237.19.81026 Boehringer Ingelheim Investigational Site
city: Hiroshima, Fukuyama
country: Japan
facility: 1237.19.81101 Boehringer Ingelheim Investigational Site
city: Hiroshima, Hiroshima
country: Japan
facility: 1237.19.81104 Boehringer Ingelheim Investigational Site
city: Hiroshima, Kure
country: Japan
facility: 1237.19.81102 Boehringer Ingelheim Investigational Site
city: Hiroshima, Kure
country: Japan
facility: 1237.19.81103 Boehringer Ingelheim Investigational Site
city: Hokkaido, Asahikawa
country: Japan
facility: 1237.19.81010 Boehringer Ingelheim Investigational Site
city: Hokkaido, Chitose
country: Japan
facility: 1237.19.81007 Boehringer Ingelheim Investigational Site
city: Hokkaido, Hakodate
country: Japan
facility: 1237.19.81012 Boehringer Ingelheim Investigational Site
city: Hokkaido, Hakodate
country: Japan
facility: 1237.19.81013 Boehringer Ingelheim Investigational Site
city: Hokkaido, Obihiro
country: Japan
facility: 1237.19.81009 Boehringer Ingelheim Investigational Site
city: Hokkaido, Obihiro
country: Japan
facility: 1237.19.81015 Boehringer Ingelheim Investigational Site
city: Hokkaido, Otaru
country: Japan
facility: 1237.19.81016 Boehringer Ingelheim Investigational Site
city: Hokkaido, Sapporo
country: Japan
facility: 1237.19.81001 Boehringer Ingelheim Investigational Site
city: Hokkaido, Sapporo
country: Japan
facility: 1237.19.81002 Boehringer Ingelheim Investigational Site
city: Hokkaido, Sapporo
country: Japan
facility: 1237.19.81004 Boehringer Ingelheim Investigational Site
city: Hokkaido, Sapporo
country: Japan
facility: 1237.19.81006 Boehringer Ingelheim Investigational Site
city: Hokkaido, Sapporo
country: Japan
facility: 1237.19.81008 Boehringer Ingelheim Investigational Site
city: Hokkaido, Sapporo
country: Japan
facility: 1237.19.81011 Boehringer Ingelheim Investigational Site
city: Hokkaido, Sapporo
country: Japan
facility: 1237.19.81014 Boehringer Ingelheim Investigational Site
city: Hokkaido, Sapporo
country: Japan
facility: 1237.19.81017 Boehringer Ingelheim Investigational Site
city: Hokkaido, Tomakomai
country: Japan
facility: 1237.19.81003 Boehringer Ingelheim Investigational Site
city: Hyogo, Himeji
country: Japan
facility: 1237.19.81090 Boehringer Ingelheim Investigational Site
city: Hyogo, Himeji
country: Japan
facility: 1237.19.81093 Boehringer Ingelheim Investigational Site
city: Hyogo, Kobe
country: Japan
facility: 1237.19.81091 Boehringer Ingelheim Investigational Site
city: Hyogo, Nishinomiya
country: Japan
facility: 1237.19.81092 Boehringer Ingelheim Investigational Site
city: Ibaraki, Hitachinaka
country: Japan
facility: 1237.19.81024 Boehringer Ingelheim Investigational Site
city: Ibaraki, Inashiki-gun
country: Japan
facility: 1237.19.81129 Boehringer Ingelheim Investigational Site
city: Ibaraki, Naka-gun
country: Japan
facility: 1237.19.81023 Boehringer Ingelheim Investigational Site
city: Ishikawa, Kanazawa
country: Japan
facility: 1237.19.81060 Boehringer Ingelheim Investigational Site
city: Iwate, Morioka
country: Japan
facility: 1237.19.81018 Boehringer Ingelheim Investigational Site
city: Kagawa, Sakaide
country: Japan
facility: 1237.19.81108 Boehringer Ingelheim Investigational Site
city: Kagawa, Takamatsu
country: Japan
facility: 1237.19.81107 Boehringer Ingelheim Investigational Site
city: Kagawa, Takamatsu
country: Japan
facility: 1237.19.81109 Boehringer Ingelheim Investigational Site
city: Kagoshima, Kagoshima
country: Japan
facility: 1237.19.81118 Boehringer Ingelheim Investigational Site
city: Kanagawa, Isehara
country: Japan
facility: 1237.19.81050 Boehringer Ingelheim Investigational Site
city: Kanagawa, Kawasaki
country: Japan
facility: 1237.19.81052 Boehringer Ingelheim Investigational Site
city: Kanagawa, Kawasaki
country: Japan
facility: 1237.19.81053 Boehringer Ingelheim Investigational Site
city: Kanagawa, Kawasaki
country: Japan
facility: 1237.19.81055 Boehringer Ingelheim Investigational Site
city: Kanagawa, Sagamihara
country: Japan
facility: 1237.19.81054 Boehringer Ingelheim Investigational Site
city: Kanagawa, Sagamihara
country: Japan
facility: 1237.19.81056 Boehringer Ingelheim Investigational Site
city: Kanagawa, Yokohama
country: Japan
facility: 1237.19.81049 Boehringer Ingelheim Investigational Site
city: Kanagawa, Yokohama
country: Japan
facility: 1237.19.81051 Boehringer Ingelheim Investigational Site
city: Kochi, Kochi
country: Japan
facility: 1237.19.81110 Boehringer Ingelheim Investigational Site
city: Kochi, Nankoku
country: Japan
facility: 1237.19.81130 Boehringer Ingelheim Investigational Site
city: Kyoto, Kyoto
country: Japan
facility: 1237.19.81077 Boehringer Ingelheim Investigational Site
city: Mie, Matsusaka
country: Japan
facility: 1237.19.81076 Boehringer Ingelheim Investigational Site
city: Miyagi, Sendai
country: Japan
facility: 1237.19.81005 Boehringer Ingelheim Investigational Site
city: Miyagi, Sendai
country: Japan
facility: 1237.19.81019 Boehringer Ingelheim Investigational Site
city: Miyagi, Sendai
country: Japan
facility: 1237.19.81020 Boehringer Ingelheim Investigational Site
city: Miyagi, Sendai
country: Japan
facility: 1237.19.81038 Boehringer Ingelheim Investigational Site
city: Nagano, Matsumoto
country: Japan
facility: 1237.19.81064 Boehringer Ingelheim Investigational Site
city: Nagano, Matumoto
country: Japan
facility: 1237.19.81063 Boehringer Ingelheim Investigational Site
city: Nagasaki, Isahaya
country: Japan
facility: 1237.19.81117 Boehringer Ingelheim Investigational Site
city: Nara, Ikoma
country: Japan
facility: 1237.19.81095 Boehringer Ingelheim Investigational Site
city: Niigata, Niigata
country: Japan
facility: 1237.19.81057 Boehringer Ingelheim Investigational Site
city: Niigata, Niigata
country: Japan
facility: 1237.19.81058 Boehringer Ingelheim Investigational Site
city: Niigata, Niigata
country: Japan
facility: 1237.19.81059 Boehringer Ingelheim Investigational Site
city: Okayama, Okayama
country: Japan
facility: 1237.19.81100 Boehringer Ingelheim Investigational Site
city: Okayama
country: Japan
facility: 1237.19.81125 Boehringer Ingelheim Investigational Site
city: Okinawa, Urasoe
country: Japan
facility: 1237.19.81119 Boehringer Ingelheim Investigational Site
city: Okinawa, Uruma
country: Japan
facility: 1237.19.81120 Boehringer Ingelheim Investigational Site
city: Osaka, Ikeda
country: Japan
facility: 1237.19.81089 Boehringer Ingelheim Investigational Site
city: Osaka, Kishiwada
country: Japan
facility: 1237.19.81082 Boehringer Ingelheim Investigational Site
city: Osaka, Osakasayama
country: Japan
facility: 1237.19.81078 Boehringer Ingelheim Investigational Site
city: Osaka, Osaka
country: Japan
facility: 1237.19.81079 Boehringer Ingelheim Investigational Site
city: Osaka, Osaka
country: Japan
facility: 1237.19.81080 Boehringer Ingelheim Investigational Site
city: Osaka, Osaka
country: Japan
facility: 1237.19.81086 Boehringer Ingelheim Investigational Site
city: Osaka, Osaka
country: Japan
facility: 1237.19.81088 Boehringer Ingelheim Investigational Site
city: Osaka, Sakai
country: Japan
facility: 1237.19.81083 Boehringer Ingelheim Investigational Site
city: Osaka, Takatsuki
country: Japan
facility: 1237.19.81081 Boehringer Ingelheim Investigational Site
city: Osaka, Toyonaka
country: Japan
facility: 1237.19.81085 Boehringer Ingelheim Investigational Site
city: Osaka, Yao
country: Japan
facility: 1237.19.81087 Boehringer Ingelheim Investigational Site
city: Saitama, Koshigaya
country: Japan
facility: 1237.19.81028 Boehringer Ingelheim Investigational Site
city: Saitama, Saitama
country: Japan
facility: 1237.19.81029 Boehringer Ingelheim Investigational Site
city: Shiga
country: Japan
facility: 1237.19.81128 Boehringer Ingelheim Investigational Site
city: Shimane, Izumo
country: Japan
facility: 1237.19.81098 Boehringer Ingelheim Investigational Site
city: Shimane, Izumo
country: Japan
facility: 1237.19.81099 Boehringer Ingelheim Investigational Site
city: Shizuoka, Hamamatsu
country: Japan
facility: 1237.19.81067 Boehringer Ingelheim Investigational Site
city: Shizuoka, Shizuoka
country: Japan
facility: 1237.19.81068 Boehringer Ingelheim Investigational Site
city: Tochigi, Shimotsuke
country: Japan
facility: 1237.19.81123 Boehringer Ingelheim Investigational Site
city: Tokyo, Chiyoda-ku
country: Japan
facility: 1237.19.81075 Boehringer Ingelheim Investigational Site
city: Tokyo, Chuo-ku
country: Japan
facility: 1237.19.81036 Boehringer Ingelheim Investigational Site
city: Tokyo, Chuo-ku
country: Japan
facility: 1237.19.81040 Boehringer Ingelheim Investigational Site
city: Tokyo, Hachioji
country: Japan
facility: 1237.19.81039 Boehringer Ingelheim Investigational Site
city: Tokyo, Itabashi-ku
country: Japan
facility: 1237.19.81035 Boehringer Ingelheim Investigational Site
city: Tokyo, Itabashi-ku
country: Japan
facility: 1237.19.81043 Boehringer Ingelheim Investigational Site
city: Tokyo, Koto-ku
country: Japan
facility: 1237.19.81046 Boehringer Ingelheim Investigational Site
city: Tokyo, Meguro-ku
country: Japan
facility: 1237.19.81034 Boehringer Ingelheim Investigational Site
city: Tokyo, Minato-ku
country: Japan
facility: 1237.19.81032 Boehringer Ingelheim Investigational Site
city: Tokyo, Shinagawa-ku
country: Japan
facility: 1237.19.81047 Boehringer Ingelheim Investigational Site
city: Tokyo, Shinjuku-ku
country: Japan
facility: 1237.19.81033 Boehringer Ingelheim Investigational Site
city: Tokyo, Shinjuku-ku
country: Japan
facility: 1237.19.81041 Boehringer Ingelheim Investigational Site
city: Tokyo, Shinjuku-ku
country: Japan
facility: 1237.19.81042 Boehringer Ingelheim Investigational Site
city: Tokyo, Tachikawa
country: Japan
facility: 1237.19.81044 Boehringer Ingelheim Investigational Site
city: Tokyo, Toshima-ku
country: Japan
facility: 1237.19.81048 Boehringer Ingelheim Investigational Site
city: Tokyo,
country: Japan
facility: 1237.19.81122 Boehringer Ingelheim Investigational Site
city: Tokyo
country: Japan
facility: 1237.19.81126 Boehringer Ingelheim Investigational Site
city: Wakayama, Hidaka-gun
country: Japan
facility: 1237.19.81097 Boehringer Ingelheim Investigational Site
city: Wakayama, Wakayama
country: Japan
facility: 1237.19.81096 Boehringer Ingelheim Investigational Site
city: Yamagata, Yonezawa
country: Japan
facility: 1237.19.81021 Boehringer Ingelheim Investigational Site
city: Yamagata,
country: Japan
facility: 1237.19.81124 Boehringer Ingelheim Investigational Site
city: Yamaguchi, Iwakuni
country: Japan
facility: 1237.19.81106 Boehringer Ingelheim Investigational Site
city: Yamaguchi, Ube
country: Japan
facility: 1237.19.81105 Boehringer Ingelheim Investigational Site
city: Yamanashi, Kofu
country: Japan
facility: 1237.19.81062 Boehringer Ingelheim Investigational Site
city: Bucheon
country: Korea, Republic of
facility: 1237.19.82004 Boehringer Ingelheim Investigational Site
city: Goyang
country: Korea, Republic of
facility: 1237.19.82009 Boehringer Ingelheim Investigational Site
city: Gwangju
country: Korea, Republic of
facility: 1237.19.82006 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1237.19.82001 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1237.19.82002 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1237.19.82005 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1237.19.82007 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1237.19.82008 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1237.19.82010 Boehringer Ingelheim Investigational Site
city: Wonju
country: Korea, Republic of
facility: 1237.19.82003 Boehringer Ingelheim Investigational Site
city: Daugavpils
country: Latvia
facility: 1237.19.37103 Boehringer Ingelheim Investigational Site
city: Riga
country: Latvia
facility: 1237.19.37101 Boehringer Ingelheim Investigational Site
city: Riga
country: Latvia
facility: 1237.19.37105 Boehringer Ingelheim Investigational Site
city: Riga
country: Latvia
facility: 1237.19.37106 Boehringer Ingelheim Investigational Site
city: Tukums
country: Latvia
facility: 1237.19.37104 Boehringer Ingelheim Investigational Site
city: Valmiera
country: Latvia
facility: 1237.19.37102 Boehringer Ingelheim Investigational Site
city: Kaunas
country: Lithuania
facility: 1237.19.37002 Boehringer Ingelheim Investigational Site
city: Klaipeda
country: Lithuania
facility: 1237.19.37003 Boehringer Ingelheim Investigational Site
city: Klaipeda
country: Lithuania
facility: 1237.19.37004 Boehringer Ingelheim Investigational Site
city: Vilnius
country: Lithuania
facility: 1237.19.37001 Boehringer Ingelheim Investigational Site
city: Kota Bahru
country: Malaysia
facility: 1237.19.60006 Boehringer Ingelheim Investigational Site
city: Kuala Lumpur
country: Malaysia
facility: 1237.19.60002 Boehringer Ingelheim Investigational Site
city: Kuala Terengganu
country: Malaysia
facility: 1237.19.60004 Boehringer Ingelheim Investigational Site
city: Kuching
country: Malaysia
facility: 1237.19.60001 Boehringer Ingelheim Investigational Site
city: Aguascalientes
country: Mexico
facility: 1237.19.52006 Boehringer Ingelheim Investigational Site
city: Guadalajara
country: Mexico
facility: 1237.19.52007 Boehringer Ingelheim Investigational Site
city: León
country: Mexico
facility: 1237.19.52005 Boehringer Ingelheim Investigational Site
city: Monterrey
country: Mexico
facility: 1237.19.52001 Boehringer Ingelheim Investigational Site
city: México
country: Mexico
facility: 1237.19.52003 Boehringer Ingelheim Investigational Site
city: Tijuana
country: Mexico
facility: 1237.19.52004 Boehringer Ingelheim Investigational Site
city: Alkmaar
country: Netherlands
facility: 1237.19.31017 Boehringer Ingelheim Investigational Site
city: Almelo
country: Netherlands
facility: 1237.19.31015 Boehringer Ingelheim Investigational Site
city: Amsterdam
country: Netherlands
facility: 1237.19.31011 Boehringer Ingelheim Investigational Site
city: Assen
country: Netherlands
facility: 1237.19.31014 Boehringer Ingelheim Investigational Site
city: Breda
country: Netherlands
facility: 1237.19.31001 Boehringer Ingelheim Investigational Site
city: EDE
country: Netherlands
facility: 1237.19.31003 Boehringer Ingelheim Investigational Site
city: Eindhoven
country: Netherlands
facility: 1237.19.31002 Boehringer Ingelheim Investigational Site
city: Groningen
country: Netherlands
facility: 1237.19.31005 Boehringer Ingelheim Investigational Site
city: Harderwijk
country: Netherlands
facility: 1237.19.31010 Boehringer Ingelheim Investigational Site
city: Hoofddorp
country: Netherlands
facility: 1237.19.31012 Boehringer Ingelheim Investigational Site
city: Hoorn
country: Netherlands
facility: 1237.19.31013 Boehringer Ingelheim Investigational Site
city: Leeuwarden
country: Netherlands
facility: 1237.19.31018 Boehringer Ingelheim Investigational Site
city: Leiden
country: Netherlands
facility: 1237.19.31016 Boehringer Ingelheim Investigational Site
city: Rotterdam
country: Netherlands
facility: 1237.19.31008 Boehringer Ingelheim Investigational Site
city: Sittard - Geleen
country: Netherlands
facility: 1237.19.31007 Boehringer Ingelheim Investigational Site
city: Zutphen
country: Netherlands
facility: 1237.19.31004 Boehringer Ingelheim Investigational Site
city: Auckland, New Zealand
country: New Zealand
facility: 1237.19.64003 Boehringer Ingelheim Investigational Site
city: Christchurch Central
country: New Zealand
facility: 1237.19.64004 Boehringer Ingelheim Investigational Site
city: Christchurch
country: New Zealand
facility: 1237.19.64002 Boehringer Ingelheim Investigational Site
city: Dunedin
country: New Zealand
facility: 1237.19.64007 Boehringer Ingelheim Investigational Site
city: Dunedin
country: New Zealand
facility: 1237.19.64008 Boehringer Ingelheim Investigational Site
city: Greenlane East Auckland NZ
country: New Zealand
facility: 1237.19.64001 Boehringer Ingelheim Investigational Site
city: Hamilton
country: New Zealand
facility: 1237.19.64005 Boehringer Ingelheim Investigational Site
city: Tauranga
country: New Zealand
facility: 1237.19.64009 Boehringer Ingelheim Investigational Site
city: Arendal
country: Norway
facility: 1237.19.47002 Boehringer Ingelheim Investigational Site
city: Hamar
country: Norway
facility: 1237.19.47008 Boehringer Ingelheim Investigational Site
city: Hønefoss
country: Norway
facility: 1237.19.47001 Boehringer Ingelheim Investigational Site
city: Kløfta
country: Norway
facility: 1237.19.47006 Boehringer Ingelheim Investigational Site
city: Lierskogen
country: Norway
facility: 1237.19.47007 Boehringer Ingelheim Investigational Site
city: Oslo
country: Norway
facility: 1237.19.47004 Boehringer Ingelheim Investigational Site
city: Skedsmokorset
country: Norway
facility: 1237.19.47005 Boehringer Ingelheim Investigational Site
city: Angeles City
country: Philippines
facility: 1237.19.63007 Boehringer Ingelheim Investigational Site
city: Cebu City
country: Philippines
facility: 1237.19.63001 Boehringer Ingelheim Investigational Site
city: Dasmarinas
country: Philippines
facility: 1237.19.63003 Boehringer Ingelheim Investigational Site
city: Davao City
country: Philippines
facility: 1237.19.63008 Boehringer Ingelheim Investigational Site
city: Iloilo
country: Philippines
facility: 1237.19.63006 Boehringer Ingelheim Investigational Site
city: Manila
country: Philippines
facility: 1237.19.63005 Boehringer Ingelheim Investigational Site
city: Quezon City
country: Philippines
facility: 1237.19.63002 Boehringer Ingelheim Investigational Site
city: Bialystok
country: Poland
facility: 1237.19.48009 Boehringer Ingelheim Investigational Site
city: Bialystok
country: Poland
facility: 1237.19.48026 Boehringer Ingelheim Investigational Site
city: Bialystok
country: Poland
facility: 1237.19.48031 Boehringer Ingelheim Investigational Site
city: Bydgoszcz
country: Poland
facility: 1237.19.48010 Boehringer Ingelheim Investigational Site
city: Chojnice
country: Poland
facility: 1237.19.48029 Boehringer Ingelheim Investigational Site
city: Katowice
country: Poland
facility: 1237.19.48001 Boehringer Ingelheim Investigational Site
city: Kielce
country: Poland
facility: 1237.19.48024 Boehringer Ingelheim Investigational Site
city: Krakow
country: Poland
facility: 1237.19.48005 Boehringer Ingelheim Investigational Site
city: Krakow
country: Poland
facility: 1237.19.48007 Boehringer Ingelheim Investigational Site
city: Libiaz
country: Poland
facility: 1237.19.48015 Boehringer Ingelheim Investigational Site
city: Lodz
country: Poland
facility: 1237.19.48006 Boehringer Ingelheim Investigational Site
city: Lodz
country: Poland
facility: 1237.19.48008 Boehringer Ingelheim Investigational Site
city: Lublin
country: Poland
facility: 1237.19.48025 Boehringer Ingelheim Investigational Site
city: Olsztyn
country: Poland
facility: 1237.19.48011 Boehringer Ingelheim Investigational Site
city: Ostow Wielkopolski
country: Poland
facility: 1237.19.48013 Boehringer Ingelheim Investigational Site
city: Ostroda
country: Poland
facility: 1237.19.48019 Boehringer Ingelheim Investigational Site
city: Piaseczno
country: Poland
facility: 1237.19.48020 Boehringer Ingelheim Investigational Site
city: Poznan
country: Poland
facility: 1237.19.48002 Boehringer Ingelheim Investigational Site
city: Poznan
country: Poland
facility: 1237.19.48004 Boehringer Ingelheim Investigational Site
city: Poznan
country: Poland
facility: 1237.19.48014 Boehringer Ingelheim Investigational Site
city: Skierniewice
country: Poland
facility: 1237.19.48016 Boehringer Ingelheim Investigational Site
city: Swidnik
country: Poland
facility: 1237.19.48021 Boehringer Ingelheim Investigational Site
city: Szczecin
country: Poland
facility: 1237.19.48017 Boehringer Ingelheim Investigational Site
city: Tarnobrzeg
country: Poland
facility: 1237.19.48030 Boehringer Ingelheim Investigational Site
city: Warszawa
country: Poland
facility: 1237.19.48022 Boehringer Ingelheim Investigational Site
city: Wolomin
country: Poland
facility: 1237.19.48003 Boehringer Ingelheim Investigational Site
city: Wroclaw
country: Poland
facility: 1237.19.48023 Boehringer Ingelheim Investigational Site
city: Zawadzkie
country: Poland
facility: 1237.19.48018 Boehringer Ingelheim Investigational Site
city: Zgierz
country: Poland
facility: 1237.19.48012 Boehringer Ingelheim Investigational Site
city: Almada
country: Portugal
facility: 1237.19.35010 Boehringer Ingelheim Investigational Site
city: Amadora
country: Portugal
facility: 1237.19.35005 Boehringer Ingelheim Investigational Site
city: Aveiro
country: Portugal
facility: 1237.19.35008 Boehringer Ingelheim Investigational Site
city: Braga
country: Portugal
facility: 1237.19.35009 Boehringer Ingelheim Investigational Site
city: Coimbra
country: Portugal
facility: 1237.19.35001 Boehringer Ingelheim Investigational Site
city: Guimarães
country: Portugal
facility: 1237.19.35012 Boehringer Ingelheim Investigational Site
city: Lisboa
country: Portugal
facility: 1237.19.35002 Boehringer Ingelheim Investigational Site
city: Lisboa
country: Portugal
facility: 1237.19.35004 Boehringer Ingelheim Investigational Site
city: Porto
country: Portugal
facility: 1237.19.35003 Boehringer Ingelheim Investigational Site
city: Vila Nova de Gaia
country: Portugal
facility: 1237.19.35006 Boehringer Ingelheim Investigational Site
city: Bragadiru
country: Romania
facility: 1237.19.40007 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 1237.19.40003 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 1237.19.40004 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 1237.19.40005 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 1237.19.40008 Boehringer Ingelheim Investigational Site
city: Constanta
country: Romania
facility: 1237.19.40002 Boehringer Ingelheim Investigational Site
city: Timisoara
country: Romania
facility: 1237.19.40006 Boehringer Ingelheim Investigational Site
city: Arkhangelsk
country: Russian Federation
facility: 1237.19.70004 Boehringer Ingelheim Investigational Site
city: Barnaul
country: Russian Federation
facility: 1237.19.70028 Boehringer Ingelheim Investigational Site
city: Chelyabinsk
country: Russian Federation
facility: 1237.19.70017 Boehringer Ingelheim Investigational Site
city: Ekaterinburg
country: Russian Federation
facility: 1237.19.70020 Boehringer Ingelheim Investigational Site
city: Gatchina
country: Russian Federation
facility: 1237.19.70014 Boehringer Ingelheim Investigational Site
city: Ivanovo
country: Russian Federation
facility: 1237.19.70051 Boehringer Ingelheim Investigational Site
city: Kazan
country: Russian Federation
facility: 1237.19.70050 Boehringer Ingelheim Investigational Site
city: Kemerovo
country: Russian Federation
facility: 1237.19.70006 Boehringer Ingelheim Investigational Site
city: Kemerovo
country: Russian Federation
facility: 1237.19.70023 Boehringer Ingelheim Investigational Site
city: Kirov
country: Russian Federation
facility: 1237.19.70031 Boehringer Ingelheim Investigational Site
city: Lomonosov
country: Russian Federation
facility: 1237.19.70007 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1237.19.70002 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1237.19.70003 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1237.19.70032 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1237.19.70047 Boehringer Ingelheim Investigational Site
city: Novosibirsk
country: Russian Federation
facility: 1237.19.70024 Boehringer Ingelheim Investigational Site
city: Novosibirsk
country: Russian Federation
facility: 1237.19.70025 Boehringer Ingelheim Investigational Site
city: Novosibirsk
country: Russian Federation
facility: 1237.19.70034 Boehringer Ingelheim Investigational Site
city: Omsk
country: Russian Federation
facility: 1237.19.70035 Boehringer Ingelheim Investigational Site
city: Penza
country: Russian Federation
facility: 1237.19.70033 Boehringer Ingelheim Investigational Site
city: Pskov
country: Russian Federation
facility: 1237.19.70021 Boehringer Ingelheim Investigational Site
city: Rosto-on-Don
country: Russian Federation
facility: 1237.19.70052 Boehringer Ingelheim Investigational Site
city: Rostov-na-Donu
country: Russian Federation
facility: 1237.19.70015 Boehringer Ingelheim Investigational Site
city: Saratov
country: Russian Federation
facility: 1237.19.70005 Boehringer Ingelheim Investigational Site
city: Saratov
country: Russian Federation
facility: 1237.19.70040 Boehringer Ingelheim Investigational Site
city: Saratov
country: Russian Federation
facility: 1237.19.70044 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70009 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70010 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70011 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70012 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70018 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70019 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70022 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70038 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70041 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70042 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70046 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70048 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1237.19.70049 Boehringer Ingelheim Investigational Site
city: Tomsk
country: Russian Federation
facility: 1237.19.70008 Boehringer Ingelheim Investigational Site
city: Tomsk
country: Russian Federation
facility: 1237.19.70026 Boehringer Ingelheim Investigational Site
city: Ulyanovsk
country: Russian Federation
facility: 1237.19.70037 Boehringer Ingelheim Investigational Site
city: Volgograd
country: Russian Federation
facility: 1237.19.70030 Boehringer Ingelheim Investigational Site
city: Yaroslavl
country: Russian Federation
facility: 1237.19.70036 Boehringer Ingelheim Investigational Site
city: Belgrade
country: Serbia
facility: 1237.19.38101 Boehringer Ingelheim Investigational Site
city: Belgrade
country: Serbia
facility: 1237.19.38102 Boehringer Ingelheim Investigational Site
city: Belgrade
country: Serbia
facility: 1237.19.38105 Boehringer Ingelheim Investigational Site
city: Belgrade
country: Serbia
facility: 1237.19.38107 Boehringer Ingelheim Investigational Site
city: Kragujevac
country: Serbia
facility: 1237.19.38104 Boehringer Ingelheim Investigational Site
city: Nis
country: Serbia
facility: 1237.19.38108 Boehringer Ingelheim Investigational Site
city: Sombor
country: Serbia
facility: 1237.19.38106 Boehringer Ingelheim Investigational Site
city: Sremska Kamenica
country: Serbia
facility: 1237.19.38103 Boehringer Ingelheim Investigational Site
city: Singapore
country: Singapore
facility: 1237.19.65001 Boehringer Ingelheim Investigational Site
city: Singapore
country: Singapore
facility: 1237.19.65002 Boehringer Ingelheim Investigational Site
city: Bratislava
country: Slovakia
facility: 1237.19.42101 Boehringer Ingelheim Investigational Site
city: Humenne
country: Slovakia
facility: 1237.19.42104 Boehringer Ingelheim Investigational Site
city: Kosice
country: Slovakia
facility: 1237.19.42102 Boehringer Ingelheim Investigational Site
city: Martin
country: Slovakia
facility: 1237.19.42106 Boehringer Ingelheim Investigational Site
city: Poprad
country: Slovakia
facility: 1237.19.42107 Boehringer Ingelheim Investigational Site
city: Spisska Nova Ves
country: Slovakia
facility: 1237.19.42103 Boehringer Ingelheim Investigational Site
city: Vrable
country: Slovakia
facility: 1237.19.42105 Boehringer Ingelheim Investigational Site
city: Golnik
country: Slovenia
facility: 1237.19.38601 Boehringer Ingelheim Investigational Site
city: Pohorje
country: Slovenia
facility: 1237.19.38603 Boehringer Ingelheim Investigational Site
city: Topolsica
country: Slovenia
facility: 1237.19.38602 Boehringer Ingelheim Investigational Site
city: Amanzimtoti
country: South Africa
facility: 1237.19.27006 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 1237.19.27001 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 1237.19.27002 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 1237.19.27003 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 1237.19.27007 Boehringer Ingelheim Investigational Site
city: Cape Town
country: South Africa
facility: 1237.19.27009 Boehringer Ingelheim Investigational Site
city: Morningside, Sandton
country: South Africa
facility: 1237.19.27011 Boehringer Ingelheim Investigational Site
city: Parow
country: South Africa
facility: 1237.19.27010 Boehringer Ingelheim Investigational Site
city: Pretoria
country: South Africa
facility: 1237.19.27004 Boehringer Ingelheim Investigational Site
city: Pretoria
country: South Africa
facility: 1237.19.27008 Boehringer Ingelheim Investigational Site
city: Alicante
country: Spain
facility: 1237.19.34017 Boehringer Ingelheim Investigational Site
city: Aranjuez
country: Spain
facility: 1237.19.34025 Boehringer Ingelheim Investigational Site
city: Badalona
country: Spain
facility: 1237.19.34024 Boehringer Ingelheim Investigational Site
city: Barakaldo (Bilbao)
country: Spain
facility: 1237.19.34011 Boehringer Ingelheim Investigational Site
city: Barcelona
country: Spain
facility: 1237.19.34012 Boehringer Ingelheim Investigational Site
city: Barcelona
country: Spain
facility: 1237.19.34021 Boehringer Ingelheim Investigational Site
city: Centelles
country: Spain
facility: 1237.19.34028 Boehringer Ingelheim Investigational Site
city: Cáceres
country: Spain
facility: 1237.19.34007 Boehringer Ingelheim Investigational Site
city: Girona
country: Spain
facility: 1237.19.34015 Boehringer Ingelheim Investigational Site
city: Granollers (Barcelona)
country: Spain
facility: 1237.19.34027 Boehringer Ingelheim Investigational Site
city: L'Hospitalet Llobregat (bcn)
country: Spain
facility: 1237.19.34003 Boehringer Ingelheim Investigational Site
city: Liencres (Pielagos)
country: Spain
facility: 1237.19.34001 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1237.19.34005 Boehringer Ingelheim Investigational Site
city: Madrid
country: Spain
facility: 1237.19.34020 Boehringer Ingelheim Investigational Site
city: Malaga
country: Spain
facility: 1237.19.34009 Boehringer Ingelheim Investigational Site
city: Mérida
country: Spain
facility: 1237.19.34019 Boehringer Ingelheim Investigational Site
city: Palma de Mallorca
country: Spain
facility: 1237.19.34013 Boehringer Ingelheim Investigational Site
city: Pamplona
country: Spain
facility: 1237.19.34004 Boehringer Ingelheim Investigational Site
city: Pozuelo de Alarcón
country: Spain
facility: 1237.19.34018 Boehringer Ingelheim Investigational Site
city: Sabadell
country: Spain
facility: 1237.19.34023 Boehringer Ingelheim Investigational Site
city: Sevilla
country: Spain
facility: 1237.19.34014 Boehringer Ingelheim Investigational Site
city: Valencia
country: Spain
facility: 1237.19.34006 Boehringer Ingelheim Investigational Site
city: Valladolid
country: Spain
facility: 1237.19.34029 Boehringer Ingelheim Investigational Site
city: Vic
country: Spain
facility: 1237.19.34026 Boehringer Ingelheim Investigational Site
city: Vilanova i la Geltrú
country: Spain
facility: 1237.19.34022 Boehringer Ingelheim Investigational Site
city: Zaragoza
country: Spain
facility: 1237.19.34002 Boehringer Ingelheim Investigational Site
city: Göteborg
country: Sweden
facility: 1237.19.46002 Boehringer Ingelheim Investigational Site
city: Härnösand
country: Sweden
facility: 1237.19.46008 Boehringer Ingelheim Investigational Site
city: Höllviken
country: Sweden
facility: 1237.19.46004 Boehringer Ingelheim Investigational Site
city: Lund
country: Sweden
facility: 1237.19.46001 Boehringer Ingelheim Investigational Site
city: Rättvik
country: Sweden
facility: 1237.19.46005 Boehringer Ingelheim Investigational Site
city: Stockholm
country: Sweden
facility: 1237.19.46007 Boehringer Ingelheim Investigational Site
city: Ascona
country: Switzerland
facility: 1237.19.41004 Boehringer Ingelheim Investigational Site
city: Bern
country: Switzerland
facility: 1237.19.41002 Boehringer Ingelheim Investigational Site
city: Liestal
country: Switzerland
facility: 1237.19.41001 Boehringer Ingelheim Investigational Site
city: Kaohsiung City
country: Taiwan
facility: 1237.19.88012 Boehringer Ingelheim Investigational Site
city: Kaohsiung
country: Taiwan
facility: 1237.19.88010 Boehringer Ingelheim Investigational Site
city: Kaohsiung
country: Taiwan
facility: 1237.19.88011 Boehringer Ingelheim Investigational Site
city: New Taipei City
country: Taiwan
facility: 1237.19.88009 Boehringer Ingelheim Investigational Site
city: New Taipei
country: Taiwan
facility: 1237.19.88004 Boehringer Ingelheim Investigational Site
city: Taipei City
country: Taiwan
facility: 1237.19.88007 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1237.19.88001 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1237.19.88005 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1237.19.88008 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1237.19.88013 Boehringer Ingelheim Investigational Site
city: Dusit
country: Thailand
facility: 1237.19.66008 Boehringer Ingelheim Investigational Site
city: Hat Yai
country: Thailand
facility: 1237.19.66005 Boehringer Ingelheim Investigational Site
city: Maerim
country: Thailand
facility: 1237.19.66003 Boehringer Ingelheim Investigational Site
city: Muang
country: Thailand
facility: 1237.19.66001 Boehringer Ingelheim Investigational Site
city: Muang
country: Thailand
facility: 1237.19.66002 Boehringer Ingelheim Investigational Site
city: Patumwan
country: Thailand
facility: 1237.19.66007 Boehringer Ingelheim Investigational Site
city: Rajathevee
country: Thailand
facility: 1237.19.66004 Boehringer Ingelheim Investigational Site
city: Ankara
country: Turkey
facility: 1237.19.90006 Boehringer Ingelheim Investigational Site
city: Ankara
country: Turkey
facility: 1237.19.90007 Boehringer Ingelheim Investigational Site
city: Ankara
country: Turkey
facility: 1237.19.90015 Boehringer Ingelheim Investigational Site
city: Ankara
country: Turkey
facility: 1237.19.90016 Boehringer Ingelheim Investigational Site
city: Antalya
country: Turkey
facility: 1237.19.90008 Boehringer Ingelheim Investigational Site
city: Bursa
country: Turkey
facility: 1237.19.90010 Boehringer Ingelheim Investigational Site
city: Denizli
country: Turkey
facility: 1237.19.90002 Boehringer Ingelheim Investigational Site
city: Istanbul
country: Turkey
facility: 1237.19.90012 Boehringer Ingelheim Investigational Site
city: Istanbul
country: Turkey
facility: 1237.19.90013 Boehringer Ingelheim Investigational Site
city: Istanbul
country: Turkey
facility: 1237.19.90014 Boehringer Ingelheim Investigational Site
city: Izmir
country: Turkey
facility: 1237.19.90003 Boehringer Ingelheim Investigational Site
city: Izmir
country: Turkey
facility: 1237.19.90004 Boehringer Ingelheim Investigational Site
city: Izmir
country: Turkey
facility: 1237.19.90005 Boehringer Ingelheim Investigational Site
city: Izmir
country: Turkey
facility: 1237.19.90011 Boehringer Ingelheim Investigational Site
city: Kocaeli
country: Turkey
facility: 1237.19.90001 Boehringer Ingelheim Investigational Site
city: Konya
country: Turkey
facility: 1237.19.90009 Boehringer Ingelheim Investigational Site
city: Mersin
country: Turkey
facility: 1237.19.90000 Boehringer Ingelheim Investigational Site
city: Ivano-Frankivsk
country: Ukraine
facility: 1237.19.38009 Boehringer Ingelheim Investigational Site
city: Kharkiv
country: Ukraine
facility: 1237.19.38001 Boehringer Ingelheim Investigational Site
city: Kiev
country: Ukraine
facility: 1237.19.38005 Boehringer Ingelheim Investigational Site
city: Kiev
country: Ukraine
facility: 1237.19.38007 Boehringer Ingelheim Investigational Site
city: Kyiv
country: Ukraine
facility: 1237.19.38002 Boehringer Ingelheim Investigational Site
city: Kyiv
country: Ukraine
facility: 1237.19.38003 Boehringer Ingelheim Investigational Site
city: Kyiv
country: Ukraine
facility: 1237.19.38004 Boehringer Ingelheim Investigational Site
city: Kyiv
country: Ukraine
facility: 1237.19.38006 Boehringer Ingelheim Investigational Site
city: Odesa
country: Ukraine
facility: 1237.19.38010 Boehringer Ingelheim Investigational Site
city: Vinnytsya
country: Ukraine
facility: 1237.19.38008 Boehringer Ingelheim Investigational Site
city: Bedford
country: United Kingdom
facility: 1237.19.44008 Boehringer Ingelheim Investigational Site
city: Birmingham
country: United Kingdom
facility: 1237.19.44006 Boehringer Ingelheim Investigational Site
city: Bradford
country: United Kingdom
facility: 1237.19.44001 Boehringer Ingelheim Investigational Site
city: Chertsey
country: United Kingdom
facility: 1237.19.44002 Boehringer Ingelheim Investigational Site
city: Coventry
country: United Kingdom
facility: 1237.19.44004 Boehringer Ingelheim Investigational Site
city: Doncaster
country: United Kingdom
facility: 1237.19.44007 Boehringer Ingelheim Investigational Site
city: South Shields
country: United Kingdom
facility: 1237.19.44003 Boehringer Ingelheim Investigational Site
city: Ha Noi
country: Vietnam
facility: 1237.19.84003 Boehringer Ingelheim Investigational Site
city: Ho Chi Minh
country: Vietnam
facility: 1237.19.84001 Boehringer Ingelheim Investigational Site
city: Ho Chi Minh
country: Vietnam
facility: 1237.19.84002 Boehringer Ingelheim Investigational Site
Study officials:
affiliation: Boehringer Ingelheim
name: Boehringer Ingelheim
role: STUDY_CHAIR
References:
citation: Singh D, Wedzicha JA, Siddiqui S, de la Hoz A, Xue W, Magnussen H, Miravitlles M, Chalmers JD, Calverley PMA. Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials. Respir Res. 2020 Sep 17;21(1):240. doi: 10.1186/s12931-020-01482-1.
citation: Wedzicha JA, Buhl R, Singh D, Vogelmeier CF, de la Hoz A, Xue W, Anzueto A, Calverley PMA. Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO(R)/DYNAGITO(R) Trials. Adv Ther. 2020 Oct;37(10):4266-4279. doi: 10.1007/s12325-020-01438-3. Epub 2020 Aug 10.
citation: Ferguson GT, Buhl R, Bothner U, Hoz A, Voss F, Anzueto A, Calverley PMA. Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials. Respir Med. 2018 Oct;143:67-73. doi: 10.1016/j.rmed.2018.08.012. Epub 2018 Aug 28.
citation: Calverley PMA, Anzueto AR, Carter K, Gronke L, Hallmann C, Jenkins C, Wedzicha J, Rabe KF. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. Lancet Respir Med. 2018 May;6(5):337-344. doi: 10.1016/S2213-2600(18)30102-4. Epub 2018 Apr 5.